Life Sciences
featured
The number of women choosing to have preventive mastectomies has risen by almost 50 percent in recent years, and surveys show they are happy with the decision.
» Read MoreMore
-
*Boeing rallies after results, offsets Dow and S&P losses. NEW YORK, April 24- U.S. stocks edged lower on Wednesday as weaker-than-expected economic data and disappointing earnings, including some from the biggest corporate names, overshadowed a rally in Boeing shares.
-
*P&G slips, Boeing gains after earnings. But support for the Dow and S&P was provided Boeing Co, which jumped 4.2 percent to $91.92 as the top boost for each index after the aerospace giant reported first-quarter earnings.
-
*P&G slips, Boeing gains after earnings. "It's basically just confirming what we've seen in the economic numbers so far this month, that basically, things weren't quite as good as we thought at the end of the first quarter," said Peter Jankovskis, co-chief investment officer at OakBrook Investments LLC in Lisle, Illinois.
-
*P&G slips, Boeing gains after earnings. Boeing Co jumped 3.3 percent to $91.10 in premarket trading after the aerospace giant reported first-quarter earnings.
-
*Procter and Gamble Co slipped 1.9 percent to $81 in premarket trading after the world's largest household products maker posted third-quarter earnings.
-
MOSCOW, April 19- Russia's government commission on foreign investment has turned down U.S. group Abbott Laboratories' request to buy Russian vaccine maker Petrovax, the head of Russia's competition regulator said on Friday.
-
CHICAGO, April 11- Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China- typically the first step in making a flu vaccine- government-backed researchers had already begun testing a "seed" strain of the virus made from the genetic code posted on the Internet.
-
China has earned praise from international scientists for its handling of an outbreak of a deadly new bird flu, but a history of public health cover-ups means the Chinese public is harder to win over.
-
A strain of bird flu that has been found in humans for the first time in eastern China is not a cause for panic, the World Health Organization said on Monday, even as the number of people infected rose to 21, with six deaths.
-
*Experts in daily talks on risks posed by new China virus. LONDON, April 4- Experts from around the world are in daily talks about the threat posed by a deadly new strain of bird flu in China, including discussions on if and when to start making a vaccine.
-
*Under new CEO, Sarepta focused on Duchenne muscular dystrophy drug. *Analysts expect company to relay FDA feedback in April. April 2- After three decades without bringing a drug to market, Sarepta Therapeutics Inc stands on the verge of a breakthrough with its treatment for a crippling genetic disorder that affects one in every 3,500 newborn boys.
-
March 7- Merck& Co will bring back one of its veterans to head research and development, replacing retiring Peter Kim, who leaves behind a mixed record over the past decade at the drugmaker's highly respected laboratories.
-
March 2- Celgene Corp's experimental drug apremilast proved to be more effective than a dummy pill for psoriasis patients in a late-stage study, clearing the way for the company to file for U.S. regulatory approval in the second half of 2013..
-
NEW YORK, Feb 25- Michael Weitz was out of options. It typically has taken a decade and $1 billion to bring a new treatment to market.
-
CNBC's Jon Fortt speaks with Facebook founder & CEO Mark Zuckerberg and Apple Chairman Art Levinson about a new foundation to offer a $33 million prize for life science research. "We all think our society needs more heroes who are scientists, researchers and engineers," he says.
-
CHICAGO, Feb 1- After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year. "In my own personal view, I will consider this to be a landmark or a watershed," said Peggy Johnston, senior program officer at the Bill& Melinda Gates Foundation in Seattle.
-
NEW YORK, Jan 30- Sarepta Therapeutics Inc became the second company in as many days see its shares plunge as a result of a Twitter hoax on Wednesday after a user posed as an influential short-seller and alleged improprieties at the biopharmaceutical company.
-
*4th- qtr profit 89 cents/ share vs 82 cents a year ago. Jan 24- Medical device and bioscience company Baxter International Inc reported higher quarterly earnings on Thursday and forecast sales growth of 10 percent for 2013..
-
Japan has one of the world’s highest suicide rates. But last year the number of suicides fell below 30,000 for the first time in 15 years, thanks in part to community efforts. The CSM reports.
-
*Novartis seeks to sell Bexsero as soon as possible. ZURICH, Jan 22- Novartis won European approval for the first vaccine against meningitis B and is seeking to persuade cash-strapped governments to add it to routine vaccination programs to ensure the drug's commercial success.